ANIMATION

Vasopressin V2-Receptor Blockage

Share this animation:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

Partnering with XVIVO on our Icebreaker Merino Fibre Animation was an inspiring and rewarding experience. At all times the XVIVO group were highly professional to work with and the project was managed flawlessly.

Jeremy Moon, CEO Icebreaker
Share this animation: